Ensysce Biosciences (ENSC) Stock Overview
Ensysce Biosciences (ticker ENSC) experienced a decline of 0.8 % during the 24‑hour period ending at 12:29 AM Central Europe on Thursday, 22 April 2026.
- Current share price: USD 0.52
- Shares outstanding: 19.4 million
- Market capitalization: USD 9.8 million
- Volume traded in last 24 hours: USD 150.9 k
Since the close of the previous month, ENSC has risen 18.53 %.
- 200‑day simple moving average: USD 0.45
- 52‑week high: USD 2.26 (27 October 2025)
- 52‑week low: USD 0.23 (14 May 2026)
Comparative Performance of Related Shares (Last 24 Hours)
| Symbol | Company | 24‑hour change | Current price (USD) | Market cap (USD) |
|---|---|---|---|---|
| BTLN | Brightline Interactive | –6.54 % | 3.65 | 11.6 million |
| CNTMF | Fluent | –5.26 % | 0.02 | 11.5 million |
| PASG | Passage Bio | +0.56 % | 3.59 | 11.5 million |
| TULP | Bloomia | –8.97 % | 2.28 | 11.3 million |
| AEON | Aeon Biopharma | +0.43 % | 0.24 | 11.5 million |
Company Profile
Ensysce Biosciences, Inc. is a clinical‑stage biotechnology company focused on addressing prescription drug abuse. The company operates worldwide and is listed on the Nasdaq exchange. Its initial public offering (IPO) was completed on 1 December 2017. Additional information is available on the company’s website: www.ensysce.com .
